Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 41,699 | N/A | N/A |
| TOTAL | $43,591 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 4,623 | N/A | N/A |
| Other Non-Current Assets | 1,164 | 0 | 0 |
| TOTAL | $5,787 | $N/A | $N/A |
| Total Assets | $49,378 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 7,066 | 0 | 0 |
| Accrued Expenses | 2,529 | N/A | N/A |
| Other current liabilities | 19,680 | N/A | N/A |
| TOTAL | $29,275 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 67,764 | 0 | 0 |
| TOTAL | $68,831 | $N/A | $N/A |
| Total Liabilities | $98,106 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | N/A | N/A |
| Retained earnings | -48,077 | N/A | N/A |
| Other shareholders' equity | -1,056 | 0 | 0 |
| TOTAL | $-48,728 | $N/A | $N/A |
| Total Liabilities And Equity | $49,378 | $0 | $0 |